Preliminary results of an abiraterone acetate trial12 Oct 2010 John Neate, Chief Executive at The Prostate Cancer Charity, spoke to the Daily Telegraph, BBC Online and The Sun about the preliminary results of a trial of almost 800 men who took abiraterone acetate and lived almost four months longer than men given a placebo. Read more
University of Illinois Research07 Oct 2010 Dr Kate Holmes, Research Manager at The Prostate Cancer Charity, spoke to the Daily Mail about new research carried out by the University of Illinois, which revealed that a chemical found in babies' bottles increase the risk of men developing prostate cancer later in life. Read more
New research into BPA and prostate cancer06 Oct 2010 Our comments on new research from the University of Illinois which suggests that the chemical Bisphenol A, used in the production of plastics, can increase the risk of developing prostate cancer in rats. Read more
Cabazitaxel01 Oct 2010 Dr Sarah Cant, Head of Policy and Campaigns at The Prostate Cancer Charity, spoke to the Daily Mail and the Daily Telegraph, about cabazitaxel, a new drug which could give men with advanced prostate cancer two extra months of life. Read more
New advanced prostate cancer drug, cabazitaxel01 Oct 2010 We comment on new research published in The Lancet into a new drug, cabazitaxel, which can extend the lives of men with advanced prostate cancer that no longer responds to hormone therapies by an average of 2.4 months. Read more
Sharp raises £80,000 for The Prostate Cancer Charity24 Sep 2010 Sharp Electronics underlined the commitment of staff and employees to The Prostate Cancer Charity at the weekend, presenting a cheque for £80,000, following a hugely successful first year's partnership. Read more
Talk Sport22 Sep 2010 John Robertson, a Support & Information Specialist Helpline Nurse at The Prostate Cancer Charity, joined presenter Mike Parry's morning show on Talk Sport alongside Olympic swimmer Mark Foster to raise awareness of prostate cancer. Read more